Published 2017
| Version v1
Publication
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
- Creators
- Muraro, Paolo A
- Pasquini, Marcelo
- Atkins, Harold L
- Bowen, James D
- Farge, Dominique
- Fassas, Athanasios
- Freedman, Mark S
- Georges, George E
- Gualandi, Francesca
- Hamerschlak, Nelson
- Havrdova, Eva
- Kimiskidis, Vassilios K
- Kozak, Tomas
- MANCARDI, GIOVANNI LUIGI
- Massacesi, Luca
- Moraes, Daniela A
- Nash, Richard A
- Pavletic, Steven
- Ouyang, Jian
- Rovira, Montserrat
- Saiz, Albert
- Simoes, Belinda
- Trnený, Marek
- Zhu, Lin
- Badoglio, Manuela
- Zhong, Xiaobo
- SORMANI, MARIA PIA
- Saccardi, Riccardo
- Others:
- Muraro, Paolo A
- Pasquini, Marcelo
- Atkins, Harold L
- Bowen, James D
- Farge, Dominique
- Fassas, Athanasio
- Freedman, Mark S
- Georges, George E
- Gualandi, Francesca
- Hamerschlak, Nelson
- Havrdova, Eva
- Kimiskidis, Vassilios K
- Kozak, Toma
- Mancardi, GIOVANNI LUIGI
- Massacesi, Luca
- Moraes, Daniela A
- Nash, Richard A
- Pavletic, Steven
- Ouyang, Jian
- Rovira, Montserrat
- Saiz, Albert
- Simoes, Belinda
- Trnený, Marek
- Zhu, Lin
- Badoglio, Manuela
- Zhong, Xiaobo
- Sormani, MARIA PIA
- Saccardi, Riccardo
Description
Autologous hematopoietic stem cell transplantation (AHSCT) may be effective in aggressive forms of multiple sclerosis (MS) that fail to respond to standard therapies.
Additional details
- URL
- http://hdl.handle.net/11567/860342
- URN
- urn:oai:iris.unige.it:11567/860342
- Origin repository
- UNIGE